Placenta covering or near the internal cervical os — painless bright red bleeding in second/third trimester.
Also known as: placenta previa, low-lying placenta, marginal previa, complete previa
Overview
Placenta implanted over (complete previa) or within 2 cm of (low-lying placenta) the internal cervical os in the late second or third trimester. The 2012 Society of Maternal-Fetal Medicine simplified terminology eliminated 'partial' and 'marginal' in favor of complete vs low-lying.
Epidemiology
Affects ~1 in 200 deliveries at term (many low-lying placentas identified earlier migrate as pregnancy progresses). Risk rises with cesarean delivery history.
Try two board-style Placenta Previa questions
Real questions from the FirstPassPA bank, with the full explanation. Pick an answer — no signup, no email.
Question 1ReproductiveEasy
A 35-year-old female G3P2002 with a prior cesarean delivery presents at 36 weeks with a single episode of painless bright red vaginal bleeding that has since stopped. She is hemodynamically stable, and the fetal heart rate tracing is reassuring. Ultrasound shows a placenta completely covering the internal cervical os. Which of the following is the most appropriate management?
AExpectant management until 39 weeks
BVaginal delivery with continuous fetal monitoring
CPlanned cesarean delivery at 36-37 weeks
DImmediate cesarean delivery
Reveal answer & full explanation
Correct answer: C — Planned cesarean delivery at 36-37 weeks
AExpectant management until 39 weeks
BVaginal delivery with continuous fetal monitoring
CPlanned cesarean delivery at 36-37 weeks✓
DImmediate cesarean delivery
Why Planned cesarean delivery at 36-37 weeks is correct
Placenta previa is defined as the placenta covering the internal cervical os, and classically presents with painless bright red third-trimester bleeding
Risk factors include prior cesarean, prior uterine surgery, advanced maternal age, and multiple gestations
For a stable patient whose bleeding has resolved, ACOG recommends scheduled cesarean delivery at 36 0/7 to 37 6/7 weeks to balance prematurity risk against the risk of a future catastrophic bleed
Digital pelvic exam is contraindicated because it may provoke massive hemorrhage; betamethasone is given if preterm delivery before 37 weeks is anticipated
Why the others are wrong
Expectant management until 39 weeks — waiting to term is unsafe in previa because the longer the wait the higher the chance of a life-threatening hemorrhage; delivery is planned preterm at 36-37 weeks (anchoring on term delivery)
Vaginal delivery with continuous fetal monitoring — contraindicated, as cervical dilation over the placenta causes massive hemorrhage regardless of monitoring (right-concept-wrong-route)
Immediate cesarean delivery — reserved for uncontrolled hemorrhage, non-reassuring fetal status, or hemodynamic instability, none of which are present once bleeding has stopped and mother and fetus are stable (premature closure)
Additional high-yield points
Distinguish from placental abruption (painful bleeding) and vasa previa (fetal vessels over the os with risk of fetal exsanguination)
Question 2ReproductiveEasy
A 32-year-old female at 28 weeks gestation presents with painless vaginal bleeding. She has no contractions and the fetus is in cephalic presentation. Her prior cesarean delivery was 2 years ago. Ultrasound shows the placenta completely covers the internal cervical os. Which of the following is the most appropriate management?
AInitiation of intravenous tocolytics with bed rest and daily fetal nonstress testing
BImmediate emergency cesarean delivery with maternal transfusion and neonatal resuscitation
COutpatient expectant management with pelvic rest and strict bleeding precautions
DInpatient admission with antenatal corticosteroids and continuous maternal-fetal monitoring
Reveal answer & full explanation
Correct answer: D — Inpatient admission with antenatal corticosteroids and continuous maternal-fetal monitoring
AInitiation of intravenous tocolytics with bed rest and daily fetal nonstress testing
BImmediate emergency cesarean delivery with maternal transfusion and neonatal resuscitation
COutpatient expectant management with pelvic rest and strict bleeding precautions
DInpatient admission with antenatal corticosteroids and continuous maternal-fetal monitoring✓
Why Inpatient admission with antenatal corticosteroids and continuous maternal-fetal monitoring is correct
Complete placenta previa (placenta covers the internal cervical os) with active bleeding at 28 weeks warrants inpatient admission for close observation
The patient is currently stable (no ongoing hemorrhage, no non-reassuring fetal status), so expectant management—not immediate delivery—is appropriate to prolong gestation
Antenatal corticosteroids are given between 24 and 34 weeks to accelerate fetal lung maturity in anticipation of possible preterm delivery
Continuous maternal-fetal monitoring, type and screen, and IV access allow rapid escalation if bleeding recurs or becomes severe
Delivery is by planned cesarean (vaginal delivery is contraindicated with complete previa), typically at 36–37 weeks if the patient remains stable
Why the others are wrong
Initiation of intravenous tocolytics with bed rest and daily fetal nonstress testing — she has no contractions, so tocolysis is not indicated, and this plan omits the antenatal corticosteroids that are the priority at 28 weeks
Immediate emergency cesarean delivery with maternal transfusion and neonatal resuscitation — emergent delivery is reserved for uncontrolled hemorrhage or non-reassuring fetal status, and this patient is stable
Outpatient expectant management with pelvic rest and strict bleeding precautions — outpatient care is considered only after bleeding has stopped and the steroid course is complete; active bleeding from a complete previa at 28 weeks requires admission
Additional high-yield points
Presentation: painless vaginal bleeding in the second or third trimester (sentinel bleed); uterus non-tender and soft — contrasts with placental abruption (painful, tender, board-like uterus)
Placenta accreta spectrum: prior uterine scar plus previa creates high risk; evaluate with ultrasound and MRI; deliver at a center capable of managing massive hemorrhage; cesarean-hysterectomy may be needed
🔒 Free preview limit reached
Keep reading — start your free trial
You've read your 2 free diagnosis previews. Create your free account to unlock the full Placenta Previa outline — plus all 514 diagnoses, 6,500+ board-style questions, flashcards, and an AI tutor. Your 7-day free trial includes everything, and there's no credit card required.
Prior cesarean delivery (linear with number — 1% after one, ~3% after four)
Prior placenta previa
Advanced maternal age (>35)
Multiparity
Multifetal gestation
Smoking, cocaine use
IVF and assisted reproduction
Prior uterine surgery (myomectomy, D&C)
Pathophysiology
Implantation in the lower uterine segment, near or over the cervical os, makes the placenta vulnerable to disruption as the lower segment forms and the cervix effaces in late pregnancy. The thin lower segment cannot contract effectively to control bleeding from disrupted placental vessels.
Clinical presentation
Symptoms
Painless bright red vaginal bleeding in the second or third trimester (classic — sentinel bleed)
Often unprovoked; can follow intercourse
Bleeding may resolve spontaneously, recur, or be massive
Some are asymptomatic and detected on routine ultrasound
Signs / physical exam
Bleeding without abdominal pain or uterine tenderness
Soft, non-tender uterus
Fetal heart tones usually normal initially
Hemodynamic instability in massive bleeding
Classic findings
Third-trimester woman with painless bright red vaginal bleeding, soft non-tender uterus, and placenta over or near the cervical os on TVUS.
Differential diagnosis
Placental abruption — Painful bleeding, uterine tenderness, hypertonus; often dark blood; can be concealed; usually NOT preceded by sentinel painless bleed
Vasa previa — Fetal vessels traversing membranes over cervical os; rupture of membranes → fetal exsanguination; consider with velamentous cord insertion or accessory lobe
Educational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA or PAEA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants; End of Rotation™ is a program of the Physician Assistant Education Association.